BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Xanodyne Pharmaceuticals, Inc. Laying Off 60 Pct of Work Force


9/24/2010 8:06:55 AM

Business Courier of Cincinnati -- Xanodyne Pharmaceuticals is reorganizing and laying off 60 percent of its work force.

A spokeswoman for the company said Northern Kentucky-based Xanodyne is not disclosing how many employees that amounts to or how many the company employs across its operations.

"The reduction in force will have a lesser impact on Kentucky," said Janet Barth. The company also houses employees in New Jersey and has a sales force that is spread across the country.

Xanodyne markets a portfolio of products that includes prescription pain management pharmaceuticals and a line of prenatal vitamins. In November 2009, the company announced that an expanded sales force of 250 employees would support the U.S. launch of its Zipsor pain relief medication.

Barth said employees were notified of layoffs starting yesterday and continuing Wednesday. She said the company does not expect the reorganization to involve the closure of offices.

"The strategy is they want to reshape the organization for a more longer-term strategy, look to contain overall operating costs, and they want for the longer term to be more profitable," Barth said.

Xanodyne has announced a series of changes over the past few months. Here's a look at some past coverage from the Business Courier.

http://www.bizjournals.com/cincinnati/stories/2010/09/20/daily30.html?ana=otjrss




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES